Knockdown of FOXA2 Enhances the Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells Partly Via Activation of the ERK Signalling Pathway

Chenyi Ye,Mo Chen,Erman Chen,Weixu Li,Shengdong Wang,Qianhai Ding,Cong Wang,Chenhe Zhou,Lan Tang,Weiduo Hou,Kai Hang,Rongxin He,Zhijun Pan,Wei Zhang

DOI: https://doi.org/10.1038/s41419-018-0857-6

2018-01-01

Cell Death and Disease

Abstract:Forkhead box protein A2 (FOXA2) is a core transcription factor that controls cell differentiation and may have an important role in bone metabolism. However, the role of FOXA2 during osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs) remains largely unknown. In this study, decreased expression of FOXA2 was observed during osteogenic differentiation of rat BMSCs (rBMSCs). FOXA2 knockdown significantly increased osteoblast-specific gene expression, the number of mineral deposits and alkaline phosphatase activity, whereas FOXA2 overexpression inhibited osteogenesis-specific activities. Moreover, extracellular signal-regulated protein kinase (ERK) signalling was upregulated following knockdown of FOXA2. The enhanced osteogenesis due to FOXA2 knockdown was partially rescued by an ERK inhibitor. Using a rat tibial defect model, a rBMSC sheet containing knocked down FOXA2 significantly improved bone healing. Collectively, these findings indicated that FOXA2 had an essential role in osteogenic differentiation of BMSCs, partly by activation of the ERK signalling pathway.